Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05529979Completed

Epione® Post-Market Clinical Follow-up Study

Role: lead

NCT06376682Not ApplicableCompleted

EPIBONE Study: a Prospective Study on Feasibility, Safety and Accuracy

Role: lead

NCT05651867Not ApplicableCompleted

EPIONE Guided Lung Evaluation

Role: lead

NCT04230642Not ApplicableCompleted

Multicenter Study to Evaluate a New Robotic Device for Image-guided Percutaneous Needle Placement

Role: lead

All 4 trials loaded